Manufacturing and Production
Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer
January 18, 2022 Manufacturing and Production
Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …
SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer
January 18, 2022 Manufacturing and Production
Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment …
Almirall and IRB Barcelona research for skin disease therapeutics discovery
January 18, 2022 Manufacturing and Production
Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral …
Abbisko Therapeutics collaborates with Lilly to discover novel molecules
January 18, 2022 Manufacturing and Production
Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …
Latest study shows positive results of CanSinoBIO’s inhaled COVID-19 vaccine as booster
January 11, 2022 Manufacturing and Production
CanSino Biologics has announced that a heterologous booster with one dose of the Inhalation Convidecia for adults aged 18 years …
Novartis to seek FDA Emergency Use Approval approval for new COVID-19 therapy
January 11, 2022 Manufacturing and Production
Novartis shared on the 10 January, that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep, has prompted …
Largest Phase III hemophilia trial produces positive results
January 11, 2022 Manufacturing and Production
BioMarin Pharmaceutical has revealed positive results from its ongoing Phase III GENEr8-1 trial on the viability of valoctocogene roxaparvovec as …
Pfizer’s Omicron vaccine to begin human trials late January
January 11, 2022 Manufacturing and Production
Albert Bourla, the CEO of Pfizer, said a COVID-19 vaccine specifically targeting the Omicron variant of the virus, alongside other …
Theranos founder Elizabeth Holmes found guilty of fraud
January 4, 2022 Manufacturing and Production
Elizabeth Holmes, founder of Theranos, has been found guilty on four of 11 charges of fraud, including one count of …
FDA expands Pfizer COVID-19 booster shot EUA for children aged 12-15
January 4, 2022 Manufacturing and Production
The FDA has bypassed its advisory panel and extended its Emergency Use Authorisation (EUA) for Pfizer BioNTech’s COVID-19 booster vaccine …
Santhera enters exclusive license agreement with Sperogenix for Vamorolone in rare diseases
January 4, 2022 Manufacturing and Production
Santhera Pharmaceuticals has announced that it has entered into an exclusive license agreement with China-based company, Sperogenix Therapeutics, specialising in …
FDA approves first injectable treatment for HIV pre-exposure prevention
December 21, 2021 Manufacturing and Production
The FDA have approved Apretude (cabotegravir extended-release injectable suspension), for use in at-risk adults and adolescents weighing at least 35 …
FDA approves bipolar depression treatment for broad range of adults
December 21, 2021 Manufacturing and Production
Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialisation of therapeutics for central nervous system (CNS) disorders, have …
European Commission approves Pfizer drug for adults with moderate-to-severe atopic dermatitis
December 14, 2021 Manufacturing and Production
The EC has approved the investigational once-daily Janus kinase 1 (JAK1) inhibitor, abrocitinib, for the treatment of moderate-to-severe atopic dermatitis …
Phase III trial results gives hope to B-Cell lymphoma patients
December 14, 2021 Manufacturing and Production
Bristol Myers Squibb (BMS) reported that interim assessment data from the Phase III TRANSFORM clinical trial of Breyanzi (lisocabtagene maraleucel; …
Latest content
